Xtrackers EURO STOXX 5 (DXET.ETF)

Close: 58.49 (+1.53), May 13, 2022
Negative

Low risk

Automatic technical analysis. Medium term, May 13, 2022

Xtrackers EURO STOXX 50 UCITS ETF 1C is within an approximate horizontal trend channel in the medium long term, which indicates further development in the same direction. The ETF has met the objective at 58.28 after the break of the double top formation. The price has now risen again, but the formation indicates a further fall. The ETF has support at euro 54.20 and resistance at euro 62.00. Volume has previously been low at price tops and high at price bottoms. This weakens the ETF and indicates increased chance of a break down. The ETF is overall assessed as technically negative for the medium long term.

Recommendation one to six months: Negative (Score: -68)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.88%3.15+2.69%
5 days-68.762.75%5.19+2.49%
22 days-30.186.75%6.80-1.78%
66 days-23.3412.35%8.60-10.36%

More analyses of Xtrackers EURO STOXX 50 UCITS ETF 1C

chart Xtrackers EURO STOXX 50 UCITS ETF 1C (DXET) Candlesticks 22 Days
Candlesticks
chart Xtrackers EURO STOXX 50 UCITS ETF 1C (DXET) Short term
Short term: Negative
chart Xtrackers EURO STOXX 50 UCITS ETF 1C (DXET) Medium term
Medium term: Negative
chart Xtrackers EURO STOXX 50 UCITS ETF 1C (DXET) Long term
Long term: Negative
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+